Voices
Real-World Evidence of Chemotherapy Effects in Advanced Pancreatic Ductal Adenocarcinoma

Real-World Evidence of Chemotherapy Effects in Advanced Pancreatic Ductal Adenocarcinoma

The Department of Cancer Genome Medicine at Yokohama City University shared a post on X:

“Real-world evidence of chemotherapy effects in advanced pancreatic ductal adenocarcinoma: prognostic significance of TP53 status in gemcitabine plus nab-paclitaxel therapy.”

Authors: M. Sugimori, A. Hirotani, H. Yamazaki, M. Oshi, K. Kawashima, H. Tsuchiya, Y. Kanemaru, Y. Suzuki, S. Onodera, H. Miwa, A. Nozaki, K. Sugimori, C. Kunisaki, M. Kudo, M. Morimoto, S. Maeda

Read the Full Article.

Real-World Evidence of Chemotherapy Effects in Advanced Pancreatic Ductal Adenocarcinoma

More posts on OncoDaily.

A. Hirotani A. Nozaki C. Kunisaki cancer H. Miwa H. Tsuchiya H. Yamazaki K. Kawashima K. Sugimori M. Kudo M. Morimoto M. Oshi M. Sugimori OncoDaily Oncology S. Maeda S. Onodera Y. Kanemaru Y. Suzuki